93 related articles for article (PubMed ID: 29485414)
1. The Association between Serum 25-Hydroxyvitamin D and Cancer Risk: Results from the Prospective KORA F4 Study.
Cheney CP; Thorand B; Huth C; Berger K; Peters A; Seifert-Klauss V; Kiechle M; Strauch K; Quante AS
Oncol Res Treat; 2018; 41(3):117-121. PubMed ID: 29485414
[TBL] [Abstract][Full Text] [Related]
2. Prospective study of serum vitamin D and cancer mortality in the United States.
Freedman DM; Looker AC; Chang SC; Graubard BI
J Natl Cancer Inst; 2007 Nov; 99(21):1594-602. PubMed ID: 17971526
[TBL] [Abstract][Full Text] [Related]
3. Serum 25-hydroxyvitamin d and cancer risk in older adults: results from a large German prospective cohort study.
Ordóñez-Mena JM; Schöttker B; Haug U; Müller H; Köhrle J; Schomburg L; Holleczek B; Brenner H
Cancer Epidemiol Biomarkers Prev; 2013 May; 22(5):905-16. PubMed ID: 23462913
[TBL] [Abstract][Full Text] [Related]
4. The inverse association between serum 25-hydroxyvitamin D and mortality may be modified by vitamin A status and use of vitamin A supplements.
Schmutz EA; Zimmermann MB; Rohrmann S
Eur J Nutr; 2016 Feb; 55(1):393-402. PubMed ID: 25701092
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of vitamin D are not associated with future risk of venous thromboembolism. The Tromsø Study.
Brodin E; Lerstad G; Grimnes G; Brækkan SK; Vik A; Brox J; Svartberg J; Jorde R; Hansen JB
Thromb Haemost; 2013 May; 109(5):885-90. PubMed ID: 23446951
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer risk markedly lower with serum 25-hydroxyvitamin D concentrations ≥60 vs <20 ng/ml (150 vs 50 nmol/L): Pooled analysis of two randomized trials and a prospective cohort.
McDonnell SL; Baggerly CA; French CB; Baggerly LL; Garland CF; Gorham ED; Hollis BW; Trump DL; Lappe JM
PLoS One; 2018; 13(6):e0199265. PubMed ID: 29906273
[TBL] [Abstract][Full Text] [Related]
7. Plasma Vitamin D Level and Change in Albuminuria and eGFR According to Sodium Intake.
Keyzer CA; Lambers-Heerspink HJ; Joosten MM; Deetman PE; Gansevoort RT; Navis G; Kema IP; de Zeeuw D; Bakker SJ; de Borst MH;
Clin J Am Soc Nephrol; 2015 Dec; 10(12):2119-27. PubMed ID: 26450935
[TBL] [Abstract][Full Text] [Related]
8. Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study.
Vrieling A; Hein R; Abbas S; Schneeweiss A; Flesch-Janys D; Chang-Claude J
Breast Cancer Res; 2011 Jul; 13(4):R74. PubMed ID: 21791049
[TBL] [Abstract][Full Text] [Related]
9. Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults.
Ginde AA; Scragg R; Schwartz RS; Camargo CA
J Am Geriatr Soc; 2009 Sep; 57(9):1595-603. PubMed ID: 19549021
[TBL] [Abstract][Full Text] [Related]
10. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer.
Li H; Stampfer MJ; Hollis JB; Mucci LA; Gaziano JM; Hunter D; Giovannucci EL; Ma J
PLoS Med; 2007 Mar; 4(3):e103. PubMed ID: 17388667
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D, PTH and the risk of overall and disease-specific mortality: Results of the Longitudinal Aging Study Amsterdam.
El Hilali J; de Koning EJ; van Ballegooijen AJ; Lips P; Sohl E; van Marwijk HWJ; Visser M; van Schoor NM
J Steroid Biochem Mol Biol; 2016 Nov; 164():386-394. PubMed ID: 26678328
[TBL] [Abstract][Full Text] [Related]
12. Association of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and parathyroid hormone with mortality among middle-aged and older European men.
Lee DM; Vanderschueren D; Boonen S; O'Neill TW; Pendleton N; Pye SR; Ravindrarajah R; Gielen E; Claessens F; Bartfai G; Casanueva FF; Finn JD; Forti G; Giwercman A; Han TS; Huhtaniemi IT; Kula K; Lean ME; Punab M; Wu FC;
Age Ageing; 2014 Jul; 43(4):528-35. PubMed ID: 24375224
[TBL] [Abstract][Full Text] [Related]
13. Long Term Association between Serum 25-Hydroxyvitamin D and Mortality in a Cohort of 4379 Men.
Meyer HE; Støer NC; Samuelsen SO; Blomhoff R; Robsahm TE; Brustad M; Giovannucci EL; Bjørge T
PLoS One; 2016; 11(3):e0151441. PubMed ID: 26986958
[TBL] [Abstract][Full Text] [Related]
14. Circulating 25-hydroxyvitamin D and postmenopausal breast cancer survival: Influence of tumor characteristics and lifestyle factors?
Vrieling A; Seibold P; Johnson TS; Heinz J; Obi N; Kaaks R; Flesch-Janys D; Chang-Claude J
Int J Cancer; 2014 Jun; 134(12):2972-83. PubMed ID: 24272459
[TBL] [Abstract][Full Text] [Related]
15. Associations of serum 25-hydroxyvitamin D level with incidence of lung cancer and histologic types in Norwegian adults: a case-cohort analysis of the HUNT study.
Sun YQ; Langhammer A; Wu C; Skorpen F; Chen Y; Nilsen TIL; Romundstad PR; Mai XM
Eur J Epidemiol; 2018 Jan; 33(1):67-77. PubMed ID: 29080012
[TBL] [Abstract][Full Text] [Related]
16. Prospective population-based study of the association between serum 25-hydroxyvitamin-D levels and the incidence of specific types of cancer.
Skaaby T; Husemoen LL; Thuesen BH; Pisinger C; Jørgensen T; Roswall N; Larsen SC; Linneberg A
Cancer Epidemiol Biomarkers Prev; 2014 Jul; 23(7):1220-9. PubMed ID: 24789846
[TBL] [Abstract][Full Text] [Related]
17. Low levels of serum 25-hydroxyvitamin D are associated with increased risk of myocardial infarction, especially in women: results from the MONICA/KORA Augsburg case-cohort study.
Karakas M; Thorand B; Zierer A; Huth C; Meisinger C; Roden M; Rottbauer W; Peters A; Koenig W; Herder C
J Clin Endocrinol Metab; 2013 Jan; 98(1):272-80. PubMed ID: 23150690
[TBL] [Abstract][Full Text] [Related]
18. Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis.
Simpson S; Taylor B; Blizzard L; Ponsonby AL; Pittas F; Tremlett H; Dwyer T; Gies P; van der Mei I
Ann Neurol; 2010 Aug; 68(2):193-203. PubMed ID: 20695012
[TBL] [Abstract][Full Text] [Related]
19. Association between Vitamin D Genetic Risk Score and Cancer Risk in a Large Cohort of U.S. Women.
Chandler PD; Tobias DK; Wang L; Smith-Warner SA; Chasman DI; Rose L; Giovannucci EL; Buring JE; Ridker PM; Cook NR; Manson JE; Sesso HD
Nutrients; 2018 Jan; 10(1):. PubMed ID: 29315215
[TBL] [Abstract][Full Text] [Related]
20. Serum 25(OH)D and incident type 2 diabetes: a cohort study.
Husemoen LL; Skaaby T; Thuesen BH; Jørgensen T; Fenger RV; Linneberg A
Eur J Clin Nutr; 2012 Dec; 66(12):1309-14. PubMed ID: 23031851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]